BioElements: Funding, Investors & Team (Sep 2026)
Our company was founded with the hope of providing an eco-friendly alternative to conventional plastic. We have been working on biodegradable solutions in all kinds of environments since 2014, adapting to customer needs and speeding up processes that would typically take hundreds of years to complete in a maximum of two. A non-toxic alternative that isn't obtained from expensive metals Today's BioElements bags, films, envelopes, packaging, and other regulated products have national and international certifications that place their effectiveness in the highest international standards. This has allowed us to expand into markets like those in Per, Colombia, Mexico, and the United States.
BioElements has raised $30.0M across 1 funding round on record, the most recent a Series A of $30.0M announced in Jan 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioElements Company Profile and Key Stats
Latest funding round on record: Jan 2023.
BioElements Funding Rounds
BioElements Founders and Leadership Team
No contact details are on record for this team yet.
BioElements Funding Compared to Other Biotechnology Startups
BioElements' latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioElements in Biotechnology and Santiago
Companies Similar to BioElements
Phage Technologies SA was founded in 2009 from three Engineers interested in Biotechnology, University Andrés…
Luyef is a mission-driven startup accelerating the transition towards a sustainable and ethical meat industry.
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
BioElements Funding FAQs
What does BioElements do?
Our company was founded with the hope of providing an eco-friendly alternative to conventional plastic. We have been working on biodegradable solutions in all kinds of environments since 2014, adapting to customer needs and speeding up processes that would typically take hundreds of years to complete in a maximum of two. A non-toxic alternative that isn't obtained from expensive metals Today's BioElements bags, films, envelopes, packaging, and other regulated products have national and international certifications that place their effectiveness in the highest international standards. This has allowed us to expand into markets like those in Per, Colombia, Mexico, and the United States.
How much funding has BioElements raised?
BioElements has raised $30.0M across 1 round on record. The most recent is a Series A of $30.0M announced in Jan 2023.
When did BioElements last raise funding?
BioElements' most recent funding round on record is a Series A of $30.0M, announced in Jan 2023.
Who is the CEO of BioElements?
Ignacio Parada Da Fonseca is listed as CEO at BioElements.
Where is BioElements headquartered?
BioElements is based in Santiago, Region Metropolitana, Chile.
How many employees does BioElements have?
BioElements is in the 11-50 employee band.
How does BioElements' funding compare to other Biotechnology startups?
BioElements' latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's BioElements Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioElements is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.